MMP-1 Over-expression Promotes Malignancy and Stem-Like Properties of Human Osteosarcoma MG-63 Cells In Vitro

Abstract

Osteosarcoma is the most common primary malignant bone tumor in childhood, and it maintains a high level of recurrence. Matrix metalloproteinase-1 (MMP-1) was found to contribute to cancer progression. The present study was to investigate the in vitro effects of MMP-1 over-expression on the proliferation, invasion, metastasis and stem-like properties of osteosarcoma MG-63 cells. The MG-63 cells were cultured and had a full length MMP-1 cDNA inserted by the lentiviral vector (MG-63^MMP-1+). MG-63 negative control and MG-63 blank control groups were established as well. MMP-1 expression was detected in MG-63^MMP-1+, MG-63 negative control and MG-63 blank control cells using qPCR, Western blotting and immunofluorescence after 24 h of culture. The cell proliferation assay was performed with a camera attached to a bioreactor, which was programmed to photograph five regions of each well every 10 min over a period of 48 h. The cell invasion assay was conducted with Matrigel to assess the invasive potential of MG-63 cells over 24 h, the qPCR analysis to measure stem cell markers, including Oct4, Sox-2, Nanog, and Pax-7, and Western blot analysis to detect invasive and metastatic potential markers TIMP-1, VEGF and BMP2/4, after 24 h of culture. Immunofluorescence was used to investigate the presence of the stem cell marker Pax-7 after 24-h culture. The results showed that over-expression of MMP-1 after transfection could significantly increase tumor cell proliferation and invasion (P<0.05, MG-63^MMP-1+versus controls). Pax-7 was highly expressed in MG-63^MMP-1+ cells, with no significant changes of Oct-4, Sox-2, and Nanog observed (P<0.05). MG-63^MMP-1+ cells showed higher expression of VEGF and BMP 2/4 proteins and lower expression of TIMP-1 protein than controls (P<0.05). It was concluded that MMP-1 over-expression in MG-63 cells contributed to the proliferation, invasion, metastasis and stem-like properties of osteosarcoma cells. Future studies should focus on in vivo effects of MMP-1 over-expression and the application of MMP-1 and Pax-7 inhibition in vivo to osteosarcoma therapies.

Keywords

osteosarcoma / MG-63 cells / matrix metalloproteinase-1 / proliferation / invasion / metastasis

References

[1] KimHJ, ChalmersPN, MorrisCD. Pediatric osteosarcoma. Curr Opin Pediatr, 2010, 22(1): 61-66

[2] OsasanS, ZhangM, ShenF, et al.. Osteosarcoma: A 21st century review. Anticancer Res, 2016, 36(9): 4391-4398

[3] FriebeleJC, PeckJ, PanX, et al.. Osteosarcoma: A meta-Analysis and review of the literature. Am J Orthop, 2015, 44(12): 547-553

[4] KansaraM, TengMW, SmythMJ, et al.. Translational biology of osteosarcoma. Nat Rev Cancer, 2014, 14(11): 722-735

[5] HuangG, NishimotoK, YangY, et al.. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases. Adv Exp Med Biol, 2014, 804: 203-217

[6] LiN, YangR, ZhangW, et al.. Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential. Cancer, 2009, 115(20): 4795-4806

[7] BurnsJS, AbdallahBM, GuldbergP, et al.. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res, 2005, 65(8): 3126-3135

[8] RatajczakMZ, Zuba-SurmaE, KuciaM, et al.. Pluripotent and multipotent stem cells in adult tissues. Adv Med Sci, 2012, 57(1): 1-17

[9] HonokiK, FujiiH, KuboA, et al.. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol Rep, 2010, 24(2): 501-505

[10] LevingsPP, McGarrySV, CurrieTP, et al.. Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res, 2009, 69(14): 5648-5655

[11] BuckinghamM, RelaixF. PAX3 and PAX7 as upstream regulators of myogenesis. Semin Cell Dev Biol, 2015, 44: 115-125

[12] LiCG, EcclesMR. PAX genes in cancer: Friends or foes?. Front Genet, 2012, 31(3): 6

[13] VargováV, PytliakM, MechírováV. Matrix metalloproteinases. EXS, 2012, 103: 1-33

[14] YadavL, PuriN, RastogiV, et al.. Matrix metalloproteinases and cancer-roles in threat and therapy. Asian Pac J Cancer Prev, 2014, 15(3): 1085-1091

[15] PickupMW, MouwJK, WeaverVM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep, 2014, 15(12): 1243-1253

[16] Hadler-OlsenE, WinbergJO, Uhlin-HansenL. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Bio, 2013, 34(4): 2041-2051

[17] PulukuriSM, RaoJS. Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. Int J Oncol, 2008, 32(4): 757-765

[18] StamenkovicI. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol, 2000, 10(6): 415-433

[19] KessenbrockK, PlaksV, WerbZ. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 2010, 141(1): 52-67

[20] WeissKR, CooperGM, JadlowiecJA, et al.. VEGF and BMP expression in mouse osteosarcoma cells. Clin Orthop Relat Res, 2006, 450: 111-117

[21] HornebeckW, LambertE, PetitfrèreE, et al.. Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie, 2005, 87(3–4): 377-383

[22] SalvatoreV, FocaroliS, TetiG, et al.. Changes in the gene expression of co-cultured human fibroblast cells and osteosarcoma cells: the role of microenvironment. Oncotarget, 2015, 6(30): 28988-28998

[23] OlguinHC, OlwinBB. Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Dev Biol, 2004, 275(2): 375-388

[24] WangW, PanH, MurrayK, et al.. Matrix metalloproteinase-1 promotes muscle cell migration and differentiation. Am J Pathol, 2009, 174(2): 541-549

[25] KessenbrockK, WangCY, WerbZ. Matrix metalloproteinases in stem cell regulation and cancer. Matrix Biol, 2015, 44–46: 184-190

[26] CargnelloM, TcherkezianJ, RouxPP. The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis, 2015, 30(2): 169-176

[27] ShayG, LynchCC, FingletonB. Moving targets: Emerging roles for MMPs in cancer progression and metastasis. Matrix Biol, 2015, 44–46: 200-206

[28] WillisAL, SabehF, LiXY, et al.. Extracellular matrix determinants and the regulation of cancer cell invasion stratagems. J Microsc, 2013, 251(3): 250-260

[29] FanHX, ChenY, NiBX, et al.. Expression of MMP-1/PAR-1 and patterns of invasion in oral squamous cell carcinoma as potential prognostic markers. Onco Targets Ther, 2015, 8: 1619-1626

[30] KimuraR, IshikawaC, RokkakuT, et al.. Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells. Biochim Biophys Acta, 2011, 1813(8): 1543-1553

[31] LouN, WangY, SunD, et al.. Isolation of stem-like cells from human MG-63 osteosarcoma cells using limiting dilution in combination with vincristine selection. Indian J Biochem Biophys, 2010, 47(6): 340-347

[32] TianJ, LiX, SiM, et al.. CD271+ osteosarcoma cells display stem-like properties. PLoS One, 2014, 9(6): e98549

[33] HusmannK, ArltMJ, MuffR, et al.. Matrix metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model. Biochim Biophys Acta, 2013, 1832(2): 347-354